Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 3/20 | 0.37 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 2/20 | 0.34 |
| ▸ | CDK2 | P24941 | 2/20 | 0.34 |
| ▸ | KDR | P35968 | 2/20 | 0.34 |
| ▸ | BRAF | P15056 | 3/20 | 0.33 |
| ▸ | TTK | P33981 | 1/20 | 0.33 |
| ▸ | RORC | P51449 | 2/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | NAMPT | P43490 | 2/20 | 0.33 |
| ▸ | F7 | P08709 | 1/20 | 0.32 |
| ▸ | F3 | P13726 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31219821 | 0.81 | TTK (0.38) | ABL1IRAK4CDK1CDK2KDR | |
| SCHEMBL31219559 | 0.74 | FYN (0.50) | GSK3BCDK1CDK2FYN | |
| SCHEMBL38662801 | 0.69 | CDK2 (0.36) | CDK1CDK2KDRTTKFYN | |
| SCHEMBL31219689 | 0.69 | CDK2 (0.35) | GSK3BCDK1CDK2KDRFYN | |
| SCHEMBL31577344 | 0.68 | BRD4 (0.30) | CDK1CDK2KDR | |
| SCHEMBL31219766 | 0.67 | CDK1 (0.38) | GSK3BCDK1CDK2KDRNAMPT | |
| SCHEMBL30381667 | 0.67 | DYRK1A (0.54) | ABL1GSK3BDYRK1ANAMPT | |
| SCHEMBL15318358 | 0.64 | NR3C1 (0.48) | F7F3 | |
| SCHEMBL30097039 | 0.62 | NAMPT (0.45) | DYRK1ANAMPT | |
| SCHEMBL26143921 | 0.62 | NAMPT (0.45) | DYRK1ANAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713096-A1 | CDK INHIBITOR COMPOUNDS | Aleksia Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024238574-A1 | CDK INHIBITOR COMPOUNDS | ALEKSIA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |